Letter From The Editor

While driving from Palm Harbor to St. Petersburg last week I was looking at the proliferation of digital billboards. It seems like there were more of them on the 35 mile drive than Best Buy had TVs on display.  The cool thing about these is that about every 25 seconds …

Last week our medical editor, Joy Pape, stirred up a little excitement with her feature on the use of metformin in patients with pre-diabetes and even those who only had a family history of diabetes. This week Ghazal Blair, our LECOM School of Pharmacy Pharm.D. Candidate, finished off her rotation …

This week two of our most favored medical professionals chime in on the effects of using medications. Our exercise guru Dr. Sheri Colberg has an interesting feature on how non-diabetes medication can affect exercise and diabetes, and our Medical Editor Joy Pape shares information on the idea of giving Metformin …

This week our medical editor, Joy Pape, was faced with patient questions on the contaminated ARB’s, that many of you have also gotten. She had been on the front side of the valsartan problem and was changing her patients to losartan, only to have to call them back. Check out …

In the last couple of weeks I have been bombarded by ads from CE companies on weight loss programs. Intermittent fasting, keto, low fat, high fat, low carb, low calorie and more. Seems like every “expert” has positive proof that their method works. And you know what, they are all …

Sometimes our obsession with clinically proven data can get in the way of patient care. We can see that this week in an article about the official indication for the dual SGLT-1/2 inhibitor sotagliflozin. To find out what our patients may end up missing, check out our article #2. Dave …

This week we focus on cardiovascular health in two of our articles. Our two interns, Dahlia Elimairi and Ghazal Blair, wanted to focus on cardiovascular health because for so many of our patients this will be their most important focus to living a long life. We look at how large …

Whether you believe in global warming or not one thing is for sure: fungi, bacteria and viruses that were frozen in the Ice Age are starting to thaw out at both of the polar ice caps and previously tundra areas. The question is, are they still active, will they come …

Metformin was approved in Canada in 1972, but did not receive approval by the FDA for type 2 diabetes until 1994, this because its sister drug phenformin happened to kill people. Although it took us 22 years to get approval we have certainly used enough in the past 25 years to make up for it. …

Years ago, we only had a couple of drugs for diabetes and we wanted more. Then, in the past 10 years, we have had an explosion of drugs and you can bet there are more coming soon. This week, Joy Pape sits down with Jeffery Emmick from Eli Lilly to …